DK0828728T3 - Phenyldihydrobenzofuraner - Google Patents

Phenyldihydrobenzofuraner

Info

Publication number
DK0828728T3
DK0828728T3 DK96916048T DK96916048T DK0828728T3 DK 0828728 T3 DK0828728 T3 DK 0828728T3 DK 96916048 T DK96916048 T DK 96916048T DK 96916048 T DK96916048 T DK 96916048T DK 0828728 T3 DK0828728 T3 DK 0828728T3
Authority
DK
Denmark
Prior art keywords
pct
date nov
sec
pub
pct pub
Prior art date
Application number
DK96916048T
Other languages
Danish (da)
English (en)
Inventor
Rolf Beume
Dieter Flockerzi
Armin Hatzelmann
Wolf-Ruediger Ulrich
Dietrich Haefner
Hans-Peter Kley
Thomas Baer
Ulrich Thibaut
Hermann Amschler
Beate Gutterer
Thomas Martin
Hildegard Boss
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of DK0828728T3 publication Critical patent/DK0828728T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/86—Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polyurethanes Or Polyureas (AREA)
DK96916048T 1995-05-18 1996-05-11 Phenyldihydrobenzofuraner DK0828728T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH147295 1995-05-18
PCT/EP1996/002031 WO1996036625A1 (de) 1995-05-18 1996-05-11 Phenyldihydrobenzofurane

Publications (1)

Publication Number Publication Date
DK0828728T3 true DK0828728T3 (da) 2003-05-19

Family

ID=4211283

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96916048T DK0828728T3 (da) 1995-05-18 1996-05-11 Phenyldihydrobenzofuraner

Country Status (12)

Country Link
US (1) US5902824A (es)
EP (1) EP0828728B1 (es)
JP (1) JPH11505236A (es)
AT (1) ATE231501T1 (es)
AU (1) AU698028B2 (es)
CA (1) CA2221357A1 (es)
CY (1) CY2466B1 (es)
DE (1) DE59610077D1 (es)
DK (1) DK0828728T3 (es)
ES (1) ES2191754T3 (es)
PT (1) PT828728E (es)
WO (1) WO1996036625A1 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514996B2 (en) 1995-05-19 2003-02-04 Kyowa Hakko Kogyo Co., Ltd. Derivatives of benzofuran or benzodioxole
AU705690B2 (en) * 1995-05-19 1999-05-27 Kyowa Hakko Kogyo Co. Ltd. Oxygen-containing heterocyclic compounds
EP2223920A3 (en) 1996-06-19 2011-09-28 Aventis Pharma Limited Substituted azabicyclic compounds
SI0941221T1 (en) * 1996-11-20 2003-10-31 Altana Pharma Ag Substituted dihydrobenzofurans as pde inhibitors
US6247016B1 (en) * 1998-08-24 2001-06-12 Lucent Technologies, Inc. Decision tree classifier with integrated building and pruning phases
GB9828340D0 (en) * 1998-12-22 1999-02-17 Novartis Ag Organic compounds
DE60043318D1 (de) 1999-08-21 2010-01-14 Nycomed Gmbh Synergistische kombination von pumafentrine und salmeterol
US6924292B2 (en) * 2000-03-23 2005-08-02 Takeda Chemical Industries, Ltd. Furoisoquinoline derivatives, process for producing the same and use thereof
ES2381862T3 (es) * 2000-09-06 2012-06-01 Mitsubishi Tanabe Pharma Corporation Preparaciones para administración por vía oral
CA2437754C (en) * 2001-02-15 2010-05-18 Tanabe Seiyaku Co., Ltd. Tablets quickly disintegrated in oral cavity
DE10205274A1 (de) * 2002-02-08 2003-08-21 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen enthaltend neben Anticholinergika heterocyclische Verbindungen
SE0202133D0 (sv) 2002-07-08 2002-07-08 Astrazeneca Ab Novel compounds
SE0302755D0 (sv) * 2003-10-17 2003-10-17 Astrazeneca Ab Novel compounds
SE0303090D0 (sv) 2003-11-20 2003-11-20 Astrazeneca Ab Novel compounds
SE0303541D0 (sv) 2003-12-22 2003-12-22 Astrazeneca Ab New compounds
PE20070341A1 (es) * 2005-07-29 2007-04-13 Wyeth Corp Derivados de pirrol como moduladores del receptor de progesterona
PE20070182A1 (es) * 2005-07-29 2007-03-06 Wyeth Corp Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド ムスカリン性受容体調節による神経発生
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
EP2068872A1 (en) 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK279958B6 (sk) * 1992-04-02 1999-06-11 Smithkline Beecham Corporation Zlúčeniny s protialergickým a protizápalovým účink
EP0634930A4 (en) * 1992-04-02 1995-02-22 Smithkline Beecham Corporation Compounds useful for treating allergic and inflammatory diseases.
DE69331265T2 (de) * 1992-04-02 2002-08-08 Smithkline Beecham Corp., Philadelphia Verbindungen zur behandlung von entzündlichen erkrankungen und zur hemmung der produktion von tumornekrosefaktor
JP3775684B2 (ja) * 1992-07-28 2006-05-17 ローン−プーラン・ロレ・リミテツド 脂肪族−またはヘテロ原子−含有連結基によりアリールまたはヘテロアリールに連結されたフェニル含有化合物
AU705690B2 (en) * 1995-05-19 1999-05-27 Kyowa Hakko Kogyo Co. Ltd. Oxygen-containing heterocyclic compounds

Also Published As

Publication number Publication date
EP0828728B1 (de) 2003-01-22
PT828728E (pt) 2003-06-30
US5902824A (en) 1999-05-11
JPH11505236A (ja) 1999-05-18
DE59610077D1 (de) 2003-02-27
WO1996036625A1 (de) 1996-11-21
AU5895496A (en) 1996-11-29
AU698028B2 (en) 1998-10-22
ES2191754T3 (es) 2003-09-16
CY2466B1 (en) 2005-06-03
CA2221357A1 (en) 1996-11-21
EP0828728A1 (de) 1998-03-18
ATE231501T1 (de) 2003-02-15

Similar Documents

Publication Publication Date Title
ATE231501T1 (de) Phenyldihydrobenzofurane
DE59610031D1 (de) Cyclohexyldihydrobenzofurane
MXPA04012965A (es) Inhibidores virales.
MY132106A (en) New pyridazin-3(2h)-one derivatives
NO20052739L (no) CCR5-antagonister som medikamenter
RS101304A (sr) Indolni, azaindolni i srodni heterociklični 4-alkenil piperidinski amidi
DE602004007239D1 (de) 4-AMINOTHIENOÄ2,3-dÜ PYRIMIDIN -6-CARBONITRIL-DERIVATIVE ZUR VERWENDUNG ALS PDE7 INHIBITOREN
TNSN03144A1 (en) Pyrrolopyrimidines as protein kinase inhibitors
NO995006D0 (no) Nye forbindelser
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
AU2003296993A8 (en) Cyclopropyl compounds as ccr5 antagonists
AU2003297048A8 (en) Cyclohexyl compounds as ccr5 antagonists
SG147450A1 (en) Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof
AU2003300911A1 (en) Heterocyclic compounds as ccr5 antagonists
EA200000355A2 (ru) Промышленные изделия
AP2003002929A0 (en) Pyrrolopyrimidines as protein kinase inhibitors
MXPA04010307A (es) Derivados 5-oxo y 5-tio de 5h-indeno`1,2-bipiridina con enlace al receptor a2a de la adenosina y actividad inhibidora de la fosfodiesterasa para el tratamiento de trastornos neurodegenerativos y enfermedades relacionadas con la inflamacion.
PT1095040E (pt) Novos benzoxazoles com actividade inibidora da pde
TW200505448A (en) 5-hydroxyindoles with n-oxide groups and the use thereof as therapeutic agents
TW200505916A (en) 7-azaindoles and the use thereof as therapeutic agents
TW200503693A (en) 4-, 6- or 7-hydroxyindoles with n-oxide groups and the use thereof as therapeutic agents
PT1259229E (pt) Utilizacao de benzotieno-[2,3-d]-pirimidinas com uma accao inibidora da pde v no tratamento do disfuncao erectil
CA2239053A1 (en) Diphenyl pyridyl ethane derivatives as pde iv inhibitors
GEP20094596B (en) Compositions comprising phosphodiesterase inhibitors for the treatment of sexual dysfunction